Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders.
Authors: Toader C, Tataru CP, Munteanu O, Covache-Busuioc RA, Serban M, Ciurea AV, Enyedi M
Neuroimmunology is reshaping the understanding of the central nervous system (CNS), revealing it as an active immune organ rather than an isolated structure. This review delves into the unprecedented discoveries transforming the field, including the emerging roles of microglia, astrocytes, and the blood-brain barrier (BBB) in orchestrating neuroimmune dynamics. Highlighting their dual roles in both repair and disease progression, we uncover how these elements contribute to the intricate pathophysiology of neurodegenerative diseases, cerebrovascular conditions, and CNS tumors. Novel insights into microglial priming, astrocytic cytokine networks, and meningeal lymphatics challenge the conventional paradigms of immune privilege, offering fresh perspectives on disease mechanisms. This work introduces groundbreaking therapeutic innovations, from precision immunotherapies to the controlled modulation of the BBB using nanotechnology and focused ultrasound. Moreover, we explore the fusion of immune modulation with neuromodulatory technologies, underscoring new frontiers for personalized medicine in previously intractable diseases. By synthesizing these advancements, we propose a transformative framework that integrates cutting-edge research with clinical translation, charting a bold path toward redefining CNS disease management in the era of precision neuroimmunology.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To synthesize recent neuroimmunology discoveries and propose a translational framework for precision immunotherapies and BBB modulation to redefine CNS disease management.
Animal model / Human subject
None — this is a review article; no experimental organisms (no species, strain, age, or sex) were reported.
Disease model
Neurodegenerative diseases, cerebrovascular conditions, and CNS tumors (general neuroimmunology context)
Cargo name and characteristics
Nanoparticles — nanotechnology-based delivery vehicles used for controlled modulation of the blood–brain barrier (BBB), deployed (in the paper) to enable targeted CNS delivery and immune modulation in combination with focused ultrasound; designed as nanoscale carriers for precision immunotherapy/BBB-crossing cargo.
Route of administration
None.
Outcomes and Safety
Summary of Outcomes
CNS immune components (microglia, astrocytes, BBB and meningeal lymphatics) actively regulate neuroinflammation and repair, thereby driving progression or resolution of neurodegenerative, cerebrovascular, and tumor pathologies and enabling targeted therapeutic modulation.
Safety-related matter
No safety issues or adverse effects are mentioned in the provided text.
Brain Region
Ultrasound Parameters
Duration of a single FUS session
None.
Focal Characteristics
High-level
Treatment frequency
multiple sessions
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search